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Diabetes prevalence is increasing exceptionally worldwide and with this come associated healthcare costs.The primary outcome of
this systematic review was to assess glycaemic control and incidence of Type 2 diabetes mellitus (T2DM) diagnosis after exercise
and dietary intervention (measured with any validated scale). The secondary outcome assessed body mass index change, weight
change, and physical exercise capacity after diet and exercise intervention (measured with any validated scale). 1,780 studies
were identified from searching electronic databases. Relevant studies went through a selection process. The inclusion criteria
for all studies were people with prediabetes diagnosed by either impaired glucose tolerance (IGT) or impaired fasting glucose
(IFG). Lifestyle adaptation reduced the incidence of diabetes development more than standard treatment. Furthermore, better
glycaemic control, improved physical exercise capacity, and increased weight reduction were observed with lifestyle intervention
over standard treatment. Finally, improvements over the long term deteriorated, highlighting problems with long-term adherence
to lifestyle changes. Overall, cumulative incidence of diabetes is drastically reduced in the intervention groups compared to control
groups (standard care). Furthermore, glycaemic control was improved in the short term, with many participants reverting to
normoglycaemia.
1. Introduction
Cumulatively, all subcategories of diabetes mellitus affect
approximately 382 million people worldwide, increasing to
an estimated 592 million by 2035 [1], emphasising the global
burden of diabetes. In UK, 3.2 million people have been
diagnosed with diabetes; a conservative estimate predicts
an increase to 5 million by 2025 [2], which equates to one
in seventeen people in UK or prevalence of 6.0% [3]. In
2010/2011, the total cost to UK for diabetes was m23.7 billion,
with m8.8 billion directly in T2DM costs, and total cost is
predicted to rise to m39.8 billion by 2035 [4]. 10% of the NHS
budget is estimated to be spent on diabetes [4, 5].
Prediabetes is a relatively recent medical term, which
raises many issues for debate [6]. The American Diabetes
Association [7] endorses the term, but both WHO [8] and
NICE [6] oppose it. The National Institute for Clinical
Excellence (NICE) considered that impaired glucose regula-
tion (IGR) should be used instead of prediabetes; inevitable
progression to diabetes is implied using prediabetes [6].
Diabetes UK (2009) states that impaired fasting glycaemia
(IFG), IGT, and glycosylated haemoglobin (HbA1c) should
be designated for usage between healthcare professionals,
with prediabetes used for the lay person.The ADA combined
IGT and IFG into the blanket term prediabetes. In 2003,
the ADA lowered the threshold for IFG and HbA1c against
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advice from other healthcare bodies [9]. Threshold lowering
was justified by needing earlier detection to reduce diabetes
development and cardiovascular disease [10]. Arguments
against the threshold change included consequences with life
insurance, possible discrimination, and causing anxiety about
developing diabetes when it might not occur [11]. Cut-off
points for prediabetes are arbitrary with no biological basis
for the test values [12].
The Da Qing IGT and Diabetes Study was one of the
original studies on prediabetes [13] and involved 577 partic-
ipants with IGT who underwent exercise and diet treatment
or diet only or exercise only. Follow-up was at 2 years and 6
years to identify any participants who had developed T2DM.
At 6 years, 67.7% of the control group (standard treatment)
developed T2DM compared with 46.0% in the diet plus
exercise group. It was assessed that the diet plus exercise
intervention decreased the risk of developing diabetes by
42%.While this study was conducted nearly two decades ago,
it highlights that prediabetes has always been present and can
potentially be treated with diet plus exercise more effectively
than the standard treatment delivered.
Oldroyd et al. [14] evaluated lifestyle modification for
improving health in individuals with IGT. 39 intervention
participants were encouraged to eat more fruit and veg-
etables, reduce fat and sugar intake, and increase dietary
fibre. Furthermore, they were encouraged to achieve 20–30
minutes of aerobic activity at least once a week. At 24
months, (after commencement of study), improvements in
2 hr plasma glucose were not significantly different between
the control and intervention groups. However, more partic-
ipants in the intervention group compared to the control
group reverted to normoglycaemia with 20% versus 13% at
24 months.
A systematic review by Orozco et al. [15] included 8
randomised controlled trials, with a total of 2241 partici-
pants using exercise plus diet treatment, compared to 2509
participants undergoing standard treatment. Interventions
included calorie restriction diets that were low in fat and
high in carbohydrates and fibre. Exercise interventions varied
but mainly consisted of 150 minutes a week of brisk walking
or other activities. The interventions were delivered by
physiotherapists and dieticians across the board. On average,
the incidence of diabetes reduced by 37% with exercise and
diet.There were also favourable effects for body weight, waist
circumference, and blood pressure. However, results of this
study should be interpreted with caution as the results are
now 7 years old and healthcare advances rapidly.
In 2009, Lindahl et al. tested 168 individuals for diabetes
incidence, diet improvement, and exercise capacity [16]. 83
underwent 1-month intensive lifestyle intervention staying at
a wellness centre where they underwent overall 140 hours of
scheduled activities and had healthymeals prepared for them;
85 underwent standard treatment at home. At the 1-year
follow-up, a 70% decrease in progression to T2DM was seen
in the intervention group. However, at 5 years, most of the
beneficial effects of the intervention had depleted; exercise
capacity was one of the only outcomes which stayed at an
appropriate level. This study highlights the fact that there is a
maintenance problem with continuing lifestyle adaptations.
The primary outcome of this systematic review was to
assess glycaemic control and incidence of T2DM diagnosis
after exercise and dietary intervention. The secondary out-
come assessed body mass index change, weight change, and
physical exercise capacity after diet and exercise intervention
(both measured with any validated scale).
2. Methods
In total, 1,780 studies were identified from searching the
electronic databases CINAHL (𝑛 = 62), MEDLINE (𝑛 =
226), EMBASE (𝑛 = 554), PsycINFO (𝑛 = 19), and Cochrane
CENTRAL (𝑛 = 919) (Figure 1). Additional searching of
reference lists from recent relevant systematic reviews and
hand searching of studies identified 4 further studies. Results
from the search were imported to Endnote X7 for assessment
of relevance to this review. 271 duplicates and 30 studies not
in the English language were removed.The remaining studies
were assessed by title alone and 1,360 studies were removed.
For the remaining studies, the abstract was assessed, with 104
studies deemed irrelevant. The full texts of the remaining 19
studies were examined against the inclusion and exclusion
criteria for the review. 10 studies were excluded after full-text
assessment.The remaining 9 studiesmet the inclusion criteria
for the review (Table 1). All assessmentswere completed twice
by different authors.
3. Excluded Studies
Of the 19 studies that had full-text review, 10 studies were
excluded for not meeting the inclusion criteria. These studies
were excluded for the following reasons: being unable to gain
access to full text (𝑛 = 2), pilot for an intended RCT (𝑛 = 1),
RCT but prediabetes is not in the inclusion criteria (𝑛 = 3),
review of previous study (𝑛 = 1), mixed intervention (𝑛 =
1), glycaemic control not an outcome (𝑛 = 1), and not for
specified period of 8-week intervention and not compared
with normal treatment (𝑛 = 1).
4. Risk of Bias in Included Studies
The methodological property of all the included studies was
assessed for risk of bias (Figure 2). The assessment involved
using the Cochrane collaborations tool for assessing risk of
bias. The tool consists of 7 areas where bias could possibly be
introduced and making judgements to assess if bias is intro-
duced or not. This is completed by answering prespecified
questions, for each of the 7 domains, and answering with
either “yes” to indicate low risk or “no” to indicate high risk.
“Unclear” indicates that too few details are available to make
a judgement on risk of bias. The final domain, other biases,
should be used to assess the study as a whole for its risk of
bias. Collected data was inputted to RevMan 5.3.
All of the studies included in this reviewwere randomised
control trials (RCTs). Critical appraisal of the studies included
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Records identied through database searching
CINAHL = 62
MEDLINE = 226
EMBASE = 554
PsycINFO = 19
Cochrane CENTRAL = 919
(n = 1,780)
Additional records through other sources (n = 4)
Total number of records searched (n = 1,784)
271 duplicates removed
30 non-English language studies removed
Records aer removal of duplicates (n = 1,483)
Studies excluded aer evaluation of title (n = 1,360)
Studies excluded aer evaluation of abstract (n = 104)
Full texts reviewed (n = 19)
Studies excluded aer full-text review with reason (n = 10)
2 = unable to gain access to full text
1= pilot for a intended RCT
3 = RCT But prediabetes is not in inclusion criteria
1= review of previous study
1= mixed intervention
1= follow-up not 8 or more weeks and 
1= glycaemic control not an outcome
Studies for inclusion in review (n = 9)
not compared with standard treatment
Figure 1: Flow chart of identification of included studies.
in this review showed that the methodological quality was
high to moderate for all the studies. None of the studies
included a high level of bias in their design. As such, all
studies were included in the review.
Random assignment to either a control or intervention
group was accomplished to a low risk in 6 of the studies
by randomisation lists prepared by a third party, computer
generated randomisation, or random allocation tables [18–
21, 24, 25].
Allocation concealment was low risk in 2 studies [20,
24], where telephone calls or numerical values were given
to denote the study group. One study was high risk [21],
where participants had knowledge of their allocation to the
intervention group. Six studies were lacking information to
make a decision on allocation concealment [17–19, 22, 23, 25].
Due to the nature of the intervention, diet, and exercise,
causing changes to the participants’ normal lifestyle, it is
difficult to conceal allocations. Therefore, this category will
not carry a large weighting in terms of selection bias for this
review.
Two studies stated that they blinded participants and
personnel [17, 24]. For 3 of the studies, it was unclear if the
participants and personnel were blinded [20, 23, 25]. The
remaining 4 studies did not blind participants or personnel
[19, 22], with 2 studies specifically stating that participants are
told what the intended intervention is for [18, 21].
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Figure 2: Risk of bias summary for included studies (produced in RevMan 5.3, 5 January 2015).
Blinding of outcome assessment was apparent in 3 studies
[21, 22, 24]. It was unclear in the remaining 6 studies whether
the outcome assessors were blinded or not [17–20, 23, 25].
All of the studies had a low risk value for both incomplete
outcome data and selective reporting. For other biases, it
is unclear due to the limited information available on the
studies. However, it is apparent that all studies maintained
a similar control group and an intervention group and no
results were missing from the final reports.
The country of origin for the studies varies widely. Two
studies are from Japan [24] and Kosaka et al., 2002, and each
of the following countries was represented by one study 1:
USA [17], Finland [19], Australia [20], England [21], India
[22], Netherlands [23], and China [25].
The majority of studies for exercise intervention recom-
mended achieving and maintaining either 150 minutes of
exercise a week or 30 minutes of exercise a day [17, 18, 21–
23, 25]. For the remaining 3 studies, one utilised a pedometer
and recommended 70,000 steps a week [24], one encouraged
participants to take part in endurance and resistance train-
ing [19], and one stated “lifestyle modification” [20]. Diet
interventions were targeted at motivating, encouraging, and
enabling participants to achieve and maintain a target BMI
or weight reduction. In one study, low glycaemic index meal
replacement was used [25] and two studies did not state a
target weight/BMI but provided healthy living advice [20, 22].
The delivery method for the interventions varied from
questionnaires to meetings with trained medical staff, moti-
vational phone calls, and group based sessions. All of these
were for a defined period of time. For the study’s outcomes,
the majority of studies used the diagnosis/prognosis of
diabetes as the primary or secondary outcome [17–19, 21,
22, 24, 25]. Two studies did not specifically use diagnosis
of diabetes as an outcome; these studies, as well as some
others, focused on plasma glucose concentration [20, 23].
Other outcomes from the studies included changes in BMI,
waist circumference, physical activity capacity, calorie intake,
and diabetes knowledge.
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Figure 3: Sample size of included studies.
5. Characteristics of Participants
The characteristics of participants are summarised in Table 2.
The study sample size (adjusted by removal of pharmacologi-
cal interventions) ranged from 88 to 2,161 in size, with overall
4,695 participants involved in either lifestyle intervention
or control groups (Figure 3). The total participants were
6,022 with pharmacological arms of studies included: 249 in
Ramachandran et al. [22] and 1,078 in Knowler et al. [17].
Figure 4 expresses the breakdown for intervention, control,
and pharmacological intervention participants for relevant
studies.
All of the studies included both male and female partic-
ipants. Apart from Kosaka et al.’s study [18] that had male
participants only, it was acknowledged in the text that a
previous study completed by the researcher included both
males and females but there was a high dropout rate for
female participants so male-only study was completed this
time. The study by Ramachandran et al. [22] stipulated that
only Asian Indian participants would be included in the
study; all other studies were open to all ethnicities; however,
coincidentally some only had one ethnicity included. The
mean age of participants ranged between 46.1± 5.7 and 62.5±
10.1.Themean bodymass index (BMI) of participants ranged
from 23.8 ± 2.1 to 34.1 ± 5.5. It should be noted that 4 of the
studies are fromAsian countries that have a lower BMI cut-off
for BMI being recognised as a risk factor for diabetes; hence,
some studies have a low BMI at baseline.
The inclusion criteria for all studies were prediabetes
diagnosed by either IGT [17, 19–23] or IFG [18, 24, 25].
All studies, apart from Lindstro¨m et al.’s study [19], stated
a numerical value for diagnosis of prediabetes. The study
by Lindstro¨m et al. states that prediabetes diagnosis is in
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Figure 4: Cumulative incidence of diabetes for control and inter-
vention groups.
accordance with the WHO [8] criteria for diagnosis, previ-
ously outlined in this review. Some of the studies had extra
inclusion criteria which included age restrictions of partici-
pants [17, 19, 21, 24, 25] and BMI above a certain threshold
[17, 19, 21, 25].
Exclusion fromall studieswas due to diagnosis of diabetes
before or during the study. Diagnosis of diabetes was com-
pleted by testing either fasting plasma glucose concentration
or glucose concentration 2 hours after a 75 g oral glucose load.
All studies, apart from Lindstro¨m et al.’s [19] and Xu et al.’s
[25] studies, state a numerical value for cut-off for diabetes
diagnosis. This means that the reviewing author is unable to
specify whatmethodwas used by Lindstro¨m et al. [19] andXu
et al. [25] to diagnose diabetes. Further exclusions for some
studies were due to chronic illness that seriously reduced
life expectancy or ability to partake in physical activity and
medications that affect glucose concentration, mental illness,
malignant neoplasm, and a range of kidney, liver, heart, and
pancreas diseases.
6. Characteristics of Interventions
Thecharacteristics of the study interventions are summarised
in Table 3. All of the included studies promoted healthy eating
and an increase in moderate physical activity. The delivery
method varied in procedure and duration. The majority of
studies used face-to-face individual interview style informa-
tion, delivered by a dietician or a physiotherapist [17–19, 21,
23]. The remaining studies used either group based sessions
carried out by a trained facilitator [20], utilised phone calls
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to provide information that coincided with 6 monthly face-
to-face follow-up meetings [22], used a pedometer to self-
motivate participants to increase exercise with face-to-face
meetings [24], or after initial educational lectures on diet and
exercise were given 3 months of meal replacements [25]. The
duration of intervention ranged from 6months to 5 years; the
majority of studies followed up participants for 36 months.
Three of the studies included offering further interven-
tions. Lindstro¨m et al. [19] offered voluntary group sessions,
low-fat cooking lessons, visits to local supermarkets, and
between-visits phone calls and letters. Penn et al. [21] offered
discount cards of 80% to physical exercise facilities and
personal trainer sessions. Finally, Roumen et al. [23] had
participants participate 3 times a year in an exercise pro-
gramme using a heartbeat watch. Two of the studies included
pharmacological interventions in separate arms [17, 22]; in
these cases, and for the purposes of this review, the results of
these arms are not reported.
All of the studies had weekly, monthly, or quarterly
consultations with the participants to review blood glucose
concentrations, weight, BMI, and food diaries among other
individual study outcomes.
7. Primary Outcome: Incidence of Diabetes
The primary outcomes for this review are the incidence
of diabetes development and glycaemic control. Table 4
summarises the primary outcome date. For each study, the
baseline characteristics were assessed to have no significant
differences between control and intervention groups which
would affect the overall outcomes. Roumen et al. [23] had an
age difference of 2 years between the control and intervention
groups, the control group’s mean age was 54 years and the
intervention group’s mean age was 52 years. The reviewing
author judged this to be an insignificant difference.
Eight studies provided information for the cumulative
incidence of diabetes for control and intervention groups.
Penn et al. [21] provided information on the cumulative
incidence difference between the intervention and control
groups and not on each individual group. Figure 5 shows the
cumulative incidence of diabetes breakdown for each study.
Cumulative incidence of diabetes is higher in the control
group than in the intervention group in all cases, apart
from Moore et al.’s study [20]. The cumulative incidence for
diabetes in the intervention and control groups, respectively,
is as follows: Knowler et al. [17], 14.4% and 28.9%; Kosaka et
al. [18], 3.0% and 9.3%; Lindstro¨m et al. [19], 9.0% and 20.0%;
Moore et al. [20], 13.0% and 7.0%; Ramachandran et al. [22],
39.3% and 55%; Roumen et al. [23], 18.0% and 38.0%; Saito
et al. [24], 12.2% and 16.6%; and Xu et al. [25], 14.6% and
17.5%. Penn et al. [21] had a cumulative incidence difference
of diabetes diagnosis of 55% less in the intervention group
compared to the control group.
Figure 5 shows the range of results for the intervention
and control groups. The cumulative incidence of diabetes
ranged from 3.0% [18] to 39.3% [22] for the intervention
group, with a mean value of 15.44% (excluding [21]) across 8
studies. The cumulative incidence of diabetes for the control
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Figure 5: Cumulative incidence of diabetes across studies exam-
ined.
group ranged from 7.0% [20] to 38.0% [22], with amean value
of 24.01%.
Two studies report incidence of diabetes in people-years.
Knowler et al. [17] report that, in the intervention group, there
were 4.8 cases per 100 people-years and, in the control group,
there were 11.0 cases per 100 people-years. Penn et al. [21] had
32.7 cases per 1000 people-years for the intervention group
and 67.1 cases per 1000 people-years for the control group.
8. Primary Outcome: Glycaemic Control
Four studies [17, 21, 22, 24] do not use glycaemic control
as either a primary or a secondary outcome. The remaining
studies reported glycaemic control in a number of ways,
ranging from improvement in oral glucose tolerance test
(OGTT) [18] to glycaemic values staying within prediabetes
range [20], change from prediabetes to normoglycaemia [20,
25], and 2-hour plasma glucose levels to show positive or
negative change from baseline [19, 20, 23, 25].
Kosaka et al. [18] reported OGTT improvement from
baseline to end of study at 4 years. Improvement of 53.8%
and 33.9% was observed for the intervention group and
the control group, respectively. Moore et al. [20] reported
cumulative incidence of prediabetes of 45% for intervention
group and 67% for control group at the end of the study.
Two studies reported change from prediabetes to normo-
glycaemia. Moore et al. [20] had results of 43% for the
intervention group and 26% for control group. Xu et al. [25]
reported results of 39% for intervention group and 7.5% for
control group.
The four studies that reported 2-hour plasma glucose
levels represented data by showing actual glycaemic levels
of difference in glycaemic levels from baseline to the end of
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the study. Two studies showing actual glycaemic levels had
results. Roumen et al. [23] had intervention group’s results
as follows: baseline, 8.59 ± 0.24, 1 year, 7.96 ± 0.29, and
3 years, 8.55 ± 0.32; and they had control group’s results
as follows: baseline, 8.46 ± 0.23, 1 year, 8.83 ± 0.29, and 3
years, 9.35 ± 0.33. Moore et al. [20] had intervention group’s
results as follows: baseline, 8.47 ± 1.39, and 6 months, 7.79 ±
2.31; and they had control group’s results as follows: baseline,
8.08 ± 1.78, and at 6 months, 7.98 ± 2.68. Two studies used
difference in glycaemic control levels. Xu et al. [25] had
intervention group’s results as follows: baseline, 8.90 ± 1.25,
with change at 1 year of −1.24 ± 0.35; and they had control
group’s results as follows: baseline, 9.24 ± 1.58, with change at
1 year of +0.85 ± 0.86. Lindstro¨m et al. [19] had intervention
group’s results as follows: baseline, 8.9 ± 1.5, change at 1 year,
−0.9 ± 1.9, and change at 3 years, −0.5 ± 2.4; and they had
control group’s results as follows: baseline, 8.9 ± 1.5, change
at 1 year, −0.3 ± 2.2, and change at 3 years, −0.1 ± 2.2. For
the studies that reported glycaemic control, the intervention
groups had vastly more improvements in 2-hour plasma
glucose concentration, glycaemic levels reverting to normal,
and less participants remainingwith prediabetes compared to
the control groups.
9. Secondary Outcome: Physical
Exercise Capacity
The results of the secondary outcomes are summarised in
Table 5. Four of the 9 studies reported on physical exercise
capacity by meeting recommended goals, maximum oxygen
volume (VO
2
), or leisure time and other time physical
activities. The 5 other studies either did not report physical
activity levels or did not report sufficient details about them
to be included in the results.
Knowler et al. [17] reported howmany intervention group
participants were meeting 150 minutes of physical activity
a week. The study had intense input up to the 24th week
mark. At this point, 74% of participants were completing 150
minutes of physical activity a week. The level of adherence
dropped to 58% by the end of the study. Levels for the control
group were not reported.
Lindstro¨m et al. [19] reported that moderate to vigorous
leisure time activity increases more significantly in the inter-
vention group compared to the control group. Results were
reported in minutes per week of exercise. The control group
at baseline was achieving 21 minutes, increasing marginally
to 23 minutes at the end of the study. Intervention group’s
baseline results were 16minutes, increasing to 50minutes per
week by the end of the study.
Ramachandran et al. [22] did not report specific figures
for physical exercise adherence; a graph is provided but it is
difficult to ascertain specific values from this. The study does
state that adherence levels changed from 41.7% at baseline to
58.8% at the end of the study for the intervention group.
Roumen et al. [23] reported both VO
2
(ltr/min) max and
days where 30 minutes of activity was met. The VO
2
level for
the intervention group at baseline was 2.22± 0.61, changing at
1 year by +0.13 ± 0.25, at 2 years by +0.10 ± 0.25, and at 3 years
by +0.05 ± 0.35. The control group’s max VO
2
at baseline was
2.13 ± 0.55, changing at 1 year by +0.02 ± 0.21, at 2 years by
−0.05 ± 0.23, and at 3 years by −0.06 ± 0.21. The number of
days the target of 30-minute activity was being met changes
for the intervention group by +0.89 ± 2.75 days and for the
control group by −0.55 ± 3.31 days.
10. Secondary Outcome: Change in BMI
Four studies reported change in BMI. Moore et al. [20]
reported BMI change for the intervention group from 29.66
± 5.33 at baseline to 28.72 ± 5.00 at 6 months. The change for
the control group was from 29.76 ± 4.94 at baseline to 29.50 ±
5.24 at 6 months. These values indicate decreases of 0.94 for
the intervention group and 0.29 for the control group.
The 3 remaining studies reported difference in BMI from
baseline at different stages of the studies. Lindstro¨m et al. [19]
had baseline results of 31.4 ± 4.5 for the intervention group,
changing at 1 year by −1.6 ± 1.8 and at 3 years by −1.3 ± 1.9.
They had baseline results of 31.1 ± 4.5 for the control group,
changing at 1 year by −0.4 ± 1.3 and at 3 years by −0.3 ± 2.0.
Roumen et al. [23] reported baseline results of 29.6 ± 3.8 for
the intervention group, changing at 1 year by −0.94 ± 1.25, at 2
years by −0.61 ± 1.49, and at 3 years by −0.36 ± 1.47. They had
baseline results of 29.2± 3.3 for the control group, changing at
1 year by −0.20 ± 1.39, at 2 years by −0.02 ± 1.17, and at 3 years
by +0.08 ± 1.80. Finally, Xu et al. [25] had baseline results of
26.80 ± 3.13 for the intervention group, changing at 1 year by
−0.66 ± 0.13. They had baseline results of 25.72 ± 3.83 for the
control group, changing at 1 year by −0.22 ± 0.15.
11. Secondary Outcome: Change in Weight
All of the studies reported on changes in mean weight (kg)
lost over the study periods. Ramachandran et al. [22] states
no significant weight change for intervention group. The 8
remaining studies either provided the baseline and end-of-
studymeanweights or provided the difference observed from
baseline to the end of the study.
Moore et al. [20] states that the baseline data for the
intervention groupwas 80.7± 16.01 and at the end of the study
it was 78.11 ± 14.98. The control group had baseline data of
82.02 ± 16.27 and at the end of the study it was 81.20 ± 17.39.
Four studies reported mean weight change from baseline
to the end of the study. Knowler et al. (2008) had a mean
weight difference of −5.6 kg for the intervention group and
−0.1 kg for the control group. Kosaka et al. [18] had mean
weight change of −2.18 kg for the intervention group and
−0.39 kg for the control group. Penn et al. [21] had change of
−2.3 kg for intervention group and change of +0.01 kg for the
control group. Finally, Saito et al. [24] had weight change of
−2.5 kg and −1.1 kg for the intervention group and the control
group, respectively.
The remaining 3 studies reported their findings in more
detail. Lindstro¨m et al. [19] had baseline results of 86.7 ± 14.0
for intervention group, changing after 1 year by −4.5 ± 5.0 and
at 3 years by −3.5 ± 5.1. They had baseline results of 85.5 ±
14.4 for control group, changing after 1 year by −1.0 ± 3.7 and
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at 3 years by −0.9 ± 5.4. Roumen et al. [23] reported baseline
results of 87.5 ± 13.7 for intervention group, changing at 1 year
by −2.77 ± 3.69, at 2 years by −1.76 ± 4.34, and at 3 years
by −1.08 ± 4.30. They had baseline results of 83.0 ± 11.7 for
control group, changing at 1 year by −0.62 ± 3.92, at 2 years
by −0.22 ± 3.26, and at 3 years by +0.16 ± 4.91. Finally, Xu et
al. [25] had baseline results of 68.24 ± 9.73 for intervention
group, changing at 1 year by −1.75 ± 0.35. They had baseline
results of 69.69 ± 1.36 for control group, changing at 1 year by
−0.55 ± 0.40.
Three of the studies further reported how many partici-
pants met the weight loss goal target. Knowler et al. (2008)
had a weight loss target of ≥7%; at 24 weeks (end of intense
input) 50% of the intervention group had achieved this. This
figure dropped at the end of the study to 38% of participants.
Lindstro¨m et al. [19] had target weight loss of ≥5%. At 1 year,
46% of the intervention group and 14% of the control group
had achieved this target. Saito et al. [24] had target weight loss
of ≥5%; 32% of the intervention group and 18% of the control
group achieved this level.
12. Discussion
12.1. Incidence of Diabetes. Theresults advocate lifestyle inter-
vention to be utilised for effectively delaying or preventing
the progression of prediabetes to T2DM. All of the studies,
besides Moore et al.’s study [20], had a reduced incidence
of diabetes with lifestyle intervention being adopted in
comparison to the control (normal treatment).These findings
correlate with previous studies assessing whether lifestyle
interventions could conceivably be adopted to reduce the
incidence of diabetes [13, 15, 26–28].
DeVegt et al. [29] found that, over a span of 6.4 years, 34%
of their study subjects, with baseline IGT, naturally developed
T2DM. Similarly, Meigs et al. [30] found that 21% of their
study subjects, with baseline IFG or IGT, progressed naturally
to T2DM during a 5-year study. Seven of the 9 studies
had diabetes incidence rates for the intervention groups
below Meigs et al.’s [30] and De Vegt et al.’s [29] findings.
Determining lifestyle intervention reduced the likelihood
of T2DM diagnosis more than natural progression. Two
studies were above the natural progression threshold [21,
22]. Penn et al. [21] did not report cumulative incidence of
diabetes, so comparison was unavailable. Ramachandran et
al. [22] had an intervention group’s cumulative incidence rate
for diabetes of 39.3%; this was a spike when compared to
other studies (Figures 4 and 5). However, study participants
were native Asian Indians who are physiologically more
susceptible to diabetes due to their ethnicity [31, 32]. The
natural progression studies were not completed on such
high risk groups. Furthermore, Ramachandran et al.’s [22]
control group had diabetes incidence rate of 55%, showing
that lifestyle intervention reduced the incidence of diabetes
compared to the control.
Moore et al.’s study [20] was the only one whose control
group had a lower incidence of diabetes than the intervention.
This was also the only study to use group based sessions
to instruct the intervention group. This tentatively indicates
that group based approach may not be as effective as one-
to-one sessions for lifestyle advice. Interventions need to
be individualised and performed by a skilled healthcare
professional trained in the specific field. The results obtained
in this study may be due Moore et al. focusing on reducing
diabetes. However, incidence of diabetes reduction for the
intervention group was similar to the other included studies.
Furthermore, follow-upwas only for 6months; longer follow-
up might affect the results.
12.2. Glycaemic Control. Five studies reported glycaemic con-
trol as a primary or secondary outcome. Results revealed that
a considerable proportion of participants in the intervention
groups reverted to normoglycaemia at an increased rate
compared to the control group. Furthermore, significant
reductions in 2-hour plasma glucose concentrations were
present with lifestyle intervention in the short term. Likewise,
there was a reduction in 2-hour plasma glucose levels for
the control groups; however, levels are substantially less
significant.
Results indicated obstacles associated with long-term
maintenance of improved glycaemic regulation. Two studies
reported glycaemic control at 3 points [19, 23]: baseline, 1 year,
and 3 years. For both studies, mean glycaemic concentration
increased at year 3 compared to year 1 after the initial
drop from baseline observed at year 1. These findings were
from two studies only, so they should be interpreted with
caution. Overall, results suggested that lifestyle intervention
in the short term had an undeniable positive effect for
glycaemic control but long-term maintenance problems.
Different individuals require different motivational input to
achieve behavioural changes; this could range from identi-
fication of prediabetes at baseline to continuous support to
change behaviours. Findings by Norris et al. [33] and Yoon
et al. [34] correlate with this review’s findings, supporting the
effectiveness of lifestyle adaptation in the short term but with
long-term adherence complications.
All included studies had intensive initial period for
study intervention. After this, face-to-face contact reduced
in frequency. Improvements in short-term glycaemic control
may be associated with the initial intense intervention.
When intensity dropped, so did glycaemic control. Kim
and Oh [35] found that an intervention group with intense
healthcare input, via regular phone call contact, had better
lifestyle adherence and consequently improved glycaemic
control than a control group with standard healthcare input.
These findings correlate with those of the review. However,
in contrast, Radhakrishnan [36] found that standard care
may be as effective as tailored individualised care for self-
management behaviours in long-term conditions. The moti-
vational effect of intense input needs to be assessed separately
and considered in future RCTs.
Improvements in glycaemic control could have been
attributed to some of the study subjects volunteering and
already having willingness to change [37]. This is likely to
lead to subsequent changes in lifestyle, which will benefit
the individual’s glycaemic control. For lifestyle interventions
to work, individuals need the initial willingness or intention
to change so they are prepared to persevere with lifestyle
modifications over the long term [38].
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12.3. Physical Exercise Capacity. Physical exercise capacity
was reported in 4 studies. Improvements in exercise capacity
for the intervention groups were more significant than for
the control group. Although increases in physical exercise
capacity were observed, the levels remain low for participants
achieving 150 minutes of activity a week. Herbst et al. [39]
found in adolescents with T2DM that over half of the
participants did not perform regular physical activity. This
is not just the case for T2DM; it is apparent with other
long-term conditions. Serour and Alqhenaei [40] found that
individuals at risk of cardiovascular disease did not complete
exercise programmes, even though they were fully aware of
the positive effects exercise has on their condition.
Physical exercise capacity at the end of the intense
intervention period compared with the end of the trial
deteriorated; however, it improved from baseline. There was
high exercise capacity in the short term, which reduced as
intervention intensity did. This was also found to be the case
in Woodard and Berry [41] and Madden et al.’s [42] works.
Furthermore, Tran et al. [43] found that, after the diabetes
aerobic and resistance exercise (DARE) trial, only 41% of
participants completed regular exercise 8 to 12 years after an
intensive 6-month trial. A positive correlation exists between
glycaemic control and physical exercise capacity. Exercise
only trials are needed to assess how exercise affects glycaemic
control.
Exercise and motivational problems were observed. Tul-
loch et al. (2013) found that continuous intervention with
exercise specialists is needed to maintain exercise levels.
Furthermore, Visram et al. [44] found that newly diagnosed
diabetics had fears and lack of understanding about exercise
which acted as a barrier. In terms of the practical implications
of this study, the assessment of self-efficacy in people with
prediabetesmayneed to be the first step in the development of
individualised lifestyle interventions and additional booster
sessions to improve long-term exercise capacity [46].
12.4. Weight and BMI. In 8 studies, lifestyle intervention
significantly reduced BMI and weight, implying that lifestyle
intervention involving diet and exercise is an effective treat-
ment for weight reduction for adults with prediabetes. These
results are not surprising as lifestyle adaptation has previously
been recognised as effective for weight and BMI reduction
with improvements in glycaemic control also identified [47,
48].
The same pattern that was present with exercise capacity
and glycaemic control is evidentwithweight andBMI change.
Over the short term, there was significant improvement in
weight. However, over the long term, both weight and BMI
increased.The results are in linewith those ofNorris et al. [49]
and Kouvelioti et al. [50] in two separate systematic reviews
of weight loss.
Weight and BMI regain occurred in the intervention
group but levels still remained significantly below the baseline
results, whereas, for some cases in the control groups, weight
regain above the original baseline results was observed. Even
with modest weight loss, every kilogram of weight loss is
associated with a 16% reduction in diabetes risk [51] and
has long-lasting effects for T2DM risk reduction [52]. The
results from the review suggest that small percentages of
sustained weight change are beneficial in reducing the risk of
prediabetes progression to T2DM and improving glycaemic
control.
13. Conclusion
This systematic review aimed to assess the feasibility of
lifestyle interventions being used to treat prediabetes and
enhance glycaemic control. The outcome measures were
to assess cumulative incidence of diabetes development,
glycaemic control, physical exercise capacity, and changes in
weight/BMI. Nine RCTs met the inclusion criteria from a
total of 1,784 relevant studies searched. The review provides
evidence for the effectiveness of lifestyle interventions to
treat prediabetes. Overall, cumulative incidence of diabetes
is drastically reduced in the intervention groups compared
to control groups (standard care). Furthermore, glycaemic
control was improved in the short term, with many par-
ticipants reverting to normoglycaemia. In the long term,
glycaemic control diminished, but glycaemic control was still
superiorly better managed than baseline results and control
groups. A similar scenario is true for weight and BMI, where
short-term reductions are replaced by long-term weight and
BMI increases. Physical exercise capacity improved at an
increased rate in the intervention groups compared to the
control groups; however, it is still significantly lower than the
recommended 150 minutes of exercise a week.
As a result of the findings from this review, lifestyle
intervention should be provided as a treatment option for
adult prediabetes patients to improve glycaemic control and
reduce the prospect of their condition developing into type
2 diabetes mellitus. However, before this is implemented in
a practice setting, more research needs to be completed to
assess how motivation to change can be maintained over
the long term. Furthermore, RCTs with large participant
numbers, completed in the UK, need to be undertaken to
assess the generalizability of lifestyle intervention treatments
for patients accessing care from the NHS.
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